Qingyi Wei, PhD

Professor in Population Health Sciences
Professor in Medicine
Member of the Duke Cancer Institute
Campus mail 103858, GSRB1 Room 3015C, Durham, NC 27710
Phone (919) 660-0562
Email address qingyi.wei@duke.edu

Qingyi Wei, MD, PhD, Professor in the Department of Medicine, is Associate Director for Cancer Control and Population Sciences, Co-leader of CCPS and Co-leader of Epidemiology and Population Genomics (Focus Area 1). He is a professor of Medicine and an internationally recognized epidemiologist focused on the molecular and genetic epidemiology of head and neck cancers, lung cancer, and melanoma. His research focuses on biomarkers and genetic determinants for the DNA repair deficient phenotype and variations in cell death. He is Editor-in-Chief of the open access journal "Cancer Medicine" and Associate Editor-in-Chief of the International Journal of Molecular Epidemiology and Genetics.

Area of Expertise: Epidemiology

Education and Training

  • Ph.D., Johns Hopkins Bloomberg School of Public Health, 1993
  • B.M., Nanjing Medical University (China), 1983

Publications

Zhang, Ruoxin, Ming Jia, Huijing Xue, Yuan Xu, Mengyun Wang, Meiling Zhu, Menghong Sun, Jianhua Chang, and Qingyi Wei. “Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy..” Sci Rep 7, no. 1 (September 6, 2017). https://doi.org/10.1038/s41598-017-10800-5.

PMID
28878296
Full Text

Li, Xin, Hongliang Liu, Christopher I. Amos, Jeffrey E. Lee, Nancy E. Thomas, Qingyi Wei, and Jiali Han. “A PGC1β genetic variant associated with nevus count and melanoma mortality..” Int J Cancer 141, no. 5 (September 1, 2017): 1066–67. https://doi.org/10.1002/ijc.30802.

PMID
28542949
Full Text

Wyss, Annah B., Mia Hashibe, Yuan-Chin Amy Lee, Shu-Chun Chuang, Joshua Muscat, Chu Chen, Stephen M. Schwartz, et al. “THE AUTHORS REPLY..” Am J Epidemiol 186, no. 5 (September 1, 2017): 625–26. https://doi.org/10.1093/aje/kwx212.

PMID
28911015
Full Text

Wang, Yanru, Jennifer A. Freedman, Hongliang Liu, Patricia G. Moorman, Terry Hyslop, Daniel J. George, Norman H. Lee, Steven R. Patierno, and Qingyi Wei. “Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer..” Int J Cancer 141, no. 4 (August 15, 2017): 731–43. https://doi.org/10.1002/ijc.30787.

PMID
28510291
Full Text

Liu, Shun, Yanru Wang, William Xue, Hongliang Liu, Yinghui Xu, Qiong Shi, Wenting Wu, et al. “Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival..” Int J Cancer 141, no. 4 (August 15, 2017): 721–30. https://doi.org/10.1002/ijc.30785.

PMID
28510328
Full Text

Fang, Shenying, Yuling Wang, Yifang Dang, Andrew Gagel, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, et al. “Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes..” J Invest Dermatol 137, no. 8 (August 2017): 1792–95. https://doi.org/10.1016/j.jid.2017.04.007.

PMID
28442307
Full Text

Shi, Qiong, Hongliang Liu, Peng Han, Chunying Li, Yanru Wang, Wenting Wu, Dakai Zhu, et al. “Genetic Variants in WNT2B and BTRC Predict Melanoma Survival..” The Journal of Investigative Dermatology 137, no. 8 (August 2017): 1749–56. https://doi.org/10.1016/j.jid.2017.04.023.

PMID
28499756
Full Text

Nagel, Zachary D., Bevin P. Engelward, David J. Brenner, Thomas J. Begley, Robert W. Sobol, Jason H. Bielas, Peter J. Stambrook, et al. “Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease..” Mutat Res 800–802 (August 2017): 14–28. https://doi.org/10.1016/j.mrfmmm.2017.03.007.

PMID
28458064
Full Text

Yin, Jieyun, Hongliang Liu, Zhensheng Liu, Kouros Owzar, Younghun Han, Li Su, Yongyue Wei, et al. “Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus..” Mol Carcinog 56, no. 6 (June 2017): 1663–72. https://doi.org/10.1002/mc.22622.

PMID
28150878
Full Text

Shi, Tingyan, Pan Wang, Caixia Xie, Sheng Yin, Di Shi, Congchong Wei, Wenbin Tang, et al. “BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer..” Int J Cancer 140, no. 9 (May 1, 2017): 2051–59. https://doi.org/10.1002/ijc.30633.

PMID
28176296
Full Text

Pages